Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage.(INTERACT-2)
Craig S. Anderson(Royal Prince Alfred Hospital), Jeyaraj Pandian(Christian Medical College, Vellore), Lauri Soinne, Katja E. Wartenberg(Leipzig University of Applied Sciences), Ronny Beer(The University of Sydney), S. Chen(Royal Australian and New Zealand College of Radiologists), Elsa Azevedo(Universidade do Porto), Yimin Huang(National Institutes of Health), Cheng‐Kai Lu(National Taiwan Normal University), Li Cui, Hideki Arima, Pablo M. Lavados(University of Leicester), Sanjiv Kaul(University of Verona), Yao-Han Li, Simes Rj, Mark Woodward(UNSW Sydney), Investigators as following Interact, Thompson Robinson(University of Leicester), Emma Heeley(University of Leicester), Stéphane Héritier(Monash University), John Chalmers(UNSW Sydney), Christophe Tzourio(The University of Sydney), K. Klijn, Mark K. Parsons, Erich Schmutzhard(Innsbruck Medical University), Marilyn Arnold, P. Redondo(The University of Sydney), Richard I. Lindley(Westmead Hospital), Markku Kaste(University of Helsinki), J. Zhang, Bruce Neal(UNSW Sydney), Christian Stapf(University of Leicester), Q. Li, Lewis B. Morgenstern(University of Michigan), S. Davis, Turgut Tatlisumak(University of Gothenburg), Chengwen Zhang, Zengqian Liu(Chinese Academy of Sciences), Jian Wang(Chengdu University of Technology), Ángel Chamorro, Shuo Wu(Anhui Medical University), E. Xu, Wang Jg, Chen Xy, Davis Sm, C. Delcourt, Silvia Ricci(Meyer Children's Hospital), Urs Fischer(University Hospital of Bern), MW Parsons, Qinglan Yang(Sichuan Agricultural University)
Unknown
January 1, 2013
Cited by 1
Related Papers
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
|Journal of the American College of Cardiology|2020|11.4k
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
|New England Journal of Medicine|2017|7.7k
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
|New England Journal of Medicine|2008|7.4k
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
|New England Journal of Medicine|2019|6k